Concanavalin A-mediated in vitro activation of lymphocytes primed against syngeneic SV40-induced tumor-associated antigens in mice into secondary effector cells capable of specifically preventing tumor growth.
D000818:Animals; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D003208:Concanavalin A / Q000494:pharmacology*; D005260:Female; D007156:Immunologic Memory; D007700:Kinetics; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects*; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology; D010835:Phytohemagglutinins / Q000494:pharmacology; D013539:Simian virus 40 / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D008070:Lipopolysaccharides; D010835:Phytohemagglutinins; D003208:Concanavalin A